HYDROCHLOROTHIAZIDE; RESERPINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrochlorothiazide; reserpine and what is the scope of patent protection?
Hydrochlorothiazide; reserpine
is the generic ingredient in eleven branded drugs marketed by Whiteworth Town Plsn, Abc Holding, Sandoz, Ivax Sub Teva Pharms, Pharmeral, Roxane, Watson Labs, Merck, Barr, West Ward, and Novartis, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.Summary for HYDROCHLOROTHIAZIDE; RESERPINE
| US Patents: | 0 |
| Tradenames: | 11 |
| Applicants: | 11 |
| NDAs: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Patent Applications: | 8 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE; RESERPINE at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE; RESERPINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| West China Hospital | Phase 4 |
| VA Office of Research and Development | |
| US Department of Veterans Affairs |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCHLOROTHIAZIDE; RESERPINE
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roxane | HYDROCHLOROTHIAZIDE W/ RESERPINE | hydrochlorothiazide; reserpine | TABLET;ORAL | 084603-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROCHLOROTHIAZIDE W/ RESERPINE | hydrochlorothiazide; reserpine | TABLET;ORAL | 086331-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | HYDROPRES 25 | hydrochlorothiazide; reserpine | TABLET;ORAL | 011958-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | HYDRO-SERP 50 | hydrochlorothiazide; reserpine | TABLET;ORAL | 085213-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROCHLOROTHIAZIDE W/ RESERPINE | hydrochlorothiazide; reserpine | TABLET;ORAL | 084467-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROCHLOROTHIAZIDE W/ RESERPINE | hydrochlorothiazide; reserpine | TABLET;ORAL | 085317-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmeral | HYDROCHLOROTHIAZIDE W/ RESERPINE | hydrochlorothiazide; reserpine | TABLET;ORAL | 085421-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
